Tongli Pharmaceuticals (USA) Inc. (TGLP) Financial
Post# of 250675
Posted On: 11/17/2014 3:49:38 AM
Tongli Pharmaceuticals (USA) Inc. (TGLP) Financials Nov 6, 2014, 8:10 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Tongli Pharmaceuticals (USA) Inc.
Fiscal year is April-March. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 7.44M 8.59M 14.66M 15.49M 11.11M
Cost of Goods Sold (COGS) incl. D&A 4.28M 4.96M 7.94M 10.06M 5.83M
COGS excluding D&A 3.93M 4.6M 7.55M 9.49M 5.19M
Depreciation & Amortization Expense 346,357 365,348 392,069 568,319 637,065
Depreciation 346,357 - 336,249 356,901 357,701
Amortization of Intangibles 0 - 55,820 211,418 279,364
Gross Income 3.16M 3.63M 6.71M 5.42M 5.27M
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 1.06M 1.73M 672,609 2.13M 1.13M
Research & Development 70,670 3,462 - - -
Other SG&A 990,358 1.73M 672,609 2.13M 1.13M
Other Operating Expense 0 0 0 0 0
Unusual Expense 0 0 159,732 0 1.91M
EBIT after Unusual Expense 0 0 (159,732) 0 (1.91M)
Non Operating Income/Expense 241,708 0 0 0 (44,965)
Non-Operating Interest Income - 93 0 - 1,088
Equity in Affiliates (Pretax) - 0 0 0 -
Interest Expense 182,285 73,340 58,225 24,133 37,709
Gross Interest Expense 182,285 73,340 58,225 24,133 37,709
Interest Capitalized - 0 0 0 0
Pretax Income 2.16M 1.83M 5.82M 3.27M 2.16M
Income Tax 254,757 855,489 1.56M 1.12M 664,316
Income Tax - Current Domestic - - 1.56M 1.47M 941,831
Income Tax - Current Foreign - - 0 0 -
Income Tax - Deferred Domestic - - 0 (179,189) (96,223)
Income Tax - Deferred Foreign - - 0 (361,321) (181,292)
Income Tax Credits (254,757) (855,489) 0 (188,995) 0
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income 1.9M 972,812 4.26M 2.15M 1.49M
Minority Interest Expense 0 0 0 0 0
Net Income 1.9M 972,812 4.26M 2.15M 1.49M
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries 1.9M 972,812 4.26M 2.15M 1.49M
Preferred Dividends 0 0 0 0 0
Net Income Available to Common 1.9M 972,812 4.26M 2.15M 1.49M
EPS (Basic) 0.19 0.10 0.37 0.17 0.11
Basic Shares Outstanding 9.97M 10.23M 11.54M 12.57M 14.1M
EPS (Diluted) 0.19 0.10 0.37 0.17 0.11
Diluted Shares Outstanding 9.97M 10.23M 11.54M 12.57M 14.1M
EBITDA 2.45M 2.27M 6.43M 3.87M 4.78M
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Tongli Pharmaceuticals (USA) Inc.
Fiscal year is April-March. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 7.44M 8.59M 14.66M 15.49M 11.11M
Cost of Goods Sold (COGS) incl. D&A 4.28M 4.96M 7.94M 10.06M 5.83M
COGS excluding D&A 3.93M 4.6M 7.55M 9.49M 5.19M
Depreciation & Amortization Expense 346,357 365,348 392,069 568,319 637,065
Depreciation 346,357 - 336,249 356,901 357,701
Amortization of Intangibles 0 - 55,820 211,418 279,364
Gross Income 3.16M 3.63M 6.71M 5.42M 5.27M
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 1.06M 1.73M 672,609 2.13M 1.13M
Research & Development 70,670 3,462 - - -
Other SG&A 990,358 1.73M 672,609 2.13M 1.13M
Other Operating Expense 0 0 0 0 0
Unusual Expense 0 0 159,732 0 1.91M
EBIT after Unusual Expense 0 0 (159,732) 0 (1.91M)
Non Operating Income/Expense 241,708 0 0 0 (44,965)
Non-Operating Interest Income - 93 0 - 1,088
Equity in Affiliates (Pretax) - 0 0 0 -
Interest Expense 182,285 73,340 58,225 24,133 37,709
Gross Interest Expense 182,285 73,340 58,225 24,133 37,709
Interest Capitalized - 0 0 0 0
Pretax Income 2.16M 1.83M 5.82M 3.27M 2.16M
Income Tax 254,757 855,489 1.56M 1.12M 664,316
Income Tax - Current Domestic - - 1.56M 1.47M 941,831
Income Tax - Current Foreign - - 0 0 -
Income Tax - Deferred Domestic - - 0 (179,189) (96,223)
Income Tax - Deferred Foreign - - 0 (361,321) (181,292)
Income Tax Credits (254,757) (855,489) 0 (188,995) 0
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income 1.9M 972,812 4.26M 2.15M 1.49M
Minority Interest Expense 0 0 0 0 0
Net Income 1.9M 972,812 4.26M 2.15M 1.49M
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries 1.9M 972,812 4.26M 2.15M 1.49M
Preferred Dividends 0 0 0 0 0
Net Income Available to Common 1.9M 972,812 4.26M 2.15M 1.49M
EPS (Basic) 0.19 0.10 0.37 0.17 0.11
Basic Shares Outstanding 9.97M 10.23M 11.54M 12.57M 14.1M
EPS (Diluted) 0.19 0.10 0.37 0.17 0.11
Diluted Shares Outstanding 9.97M 10.23M 11.54M 12.57M 14.1M
EBITDA 2.45M 2.27M 6.43M 3.87M 4.78M
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
(0)
(0)